Role of 5-hydroxytryptamine in mental diseases and its antagonism to lysergic acid derivatives (Q52170930): Preview

Role of 5-hydroxytryptamine in mental diseases and its antagonism to lysergic acid derivatives (Q52170930)
scientific article published in October 1955

Language:

Current Data About Role of 5-hydroxytryptamine in mental diseases and its antagonism to lysergic acid derivatives

(P31)

(Q13442814)

(P248)
(P698)	13265830
(P813)	Thursday, April 26, 2018
(P854)	http://europepmc.org/abstract/MED/13265830

(P304)

785-786

(P248)
(P698)	13265830
(P813)	Thursday, April 26, 2018
(P854)	http://europepmc.org/abstract/MED/13265830

(P407)

(Q1860)

(P433)

4486

(P248)
(P698)	13265830
(P813)	Thursday, April 26, 2018
(P854)	http://europepmc.org/abstract/MED/13265830

(P478)

176

(P248)
(P698)	13265830
(P813)	Thursday, April 26, 2018
(P854)	http://europepmc.org/abstract/MED/13265830

(P577)

Saturday, October 1, 1955

(P248)
(P698)	13265830
(P813)	Thursday, April 26, 2018
(P854)	http://europepmc.org/abstract/MED/13265830

(P1433)

(Q180445)

(P248)
(P698)	13265830
(P813)	Thursday, April 26, 2018
(P854)	http://europepmc.org/abstract/MED/13265830

(P1476)

"Role of 5-hydroxytryptamine in mental diseases and its antagonism to lysergic acid derivatives" (language: en)

(P248)
(P698)	13265830
(P813)	Thursday, April 26, 2018
(P854)	http://europepmc.org/abstract/MED/13265830

(P2093)

CERLETTI A

(P1545)	1

(P248)
(P698)	13265830
(P813)	Thursday, April 26, 2018
(P854)	http://europepmc.org/abstract/MED/13265830

ROTHLIN E

(P1545)	2

(P248)
(P698)	13265830
(P813)	Thursday, April 26, 2018
(P854)	http://europepmc.org/abstract/MED/13265830

(P2860)

(Q52175279)

(P248)
(P854)	https://api.crossref.org/works/10.1038%2F176785A0
(P813)	Thursday, January 7, 2021
(P887)

other details

description	scientific article published in October 1955

External Links

(P356)	10.1038/176785A0
(P698)	13265830
(P6179)	1020102409